Allogenic microglia replacement: A novel therapeutic strategy for neurological disorders
Fundamental Research · 2024-03 · 4 (2) · 237-245
DOI: 10.1016/j.fmre.2023.02.025 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Fundamental Research, 2024-03. Verfasst von Yanxia Rao und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Animal Science, MOE Frontiers Center for Brain Science, Fudan University, Shanghai 200032, China. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 176 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Microglia are resident immune cells in the central nervous system (CNS) that play vital roles in CNS development, homeostasis and disease pathogenesis. Genetic defects in microglia lead to microglial dysfunction, which in turn leads to neurological disorders. The correction of the specific genetic defects in microglia in these disorders can lead to therapeutic effects. Traditional genetic defect correction approaches are dependent on viral vector-based genetic defect corrections. However, the viruses used in these approaches, including adeno-associated viruses, lentiviruses and retroviruses, do not primarily target microglia; therefore, viral vector-based genetic defect corrections are ineffective in microglia. Microglia replacement is a novel approach to correct microglial genetic defects via replacing microglia of genetic defects with allogenic healthy microglia. In this paper, we systematically review the history, rationale and therapeutic perspectives of microglia replacement, which would be a novel strategy for treating CNS disorders.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Animal Science, MOE Frontiers Center for Brain Science, Fudan University, Shanghai 200032, China.
- Department of Neurosurgery, Huashan Hospital, Institute for Translational Brain Research, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science, MOE Innovative Center for New Drug Developm…
- Co-Innovation Center of Neuroregeneration, Nantong University, Nantong, Jiangsu 226001, China.
Zitieren
APA
Rao, Y., & Peng, B. (2024). Allogenic microglia replacement: A novel therapeutic strategy for neurological disorders. Fundamental Research, 4(2), 237-245. https://doi.org/10.1016/j.fmre.2023.02.025
Vancouver
Rao Y, Peng B. Allogenic microglia replacement: A novel therapeutic strategy for neurological disorders. Fundamental Research. 2024;4(2):237-245. doi:10.1016/j.fmre.2023.02.025
BibTeX
@article{Rao2024,
author = {Rao, Yanxia and Peng, Bo},
title = {Allogenic microglia replacement: A novel therapeutic strategy for neurological disorders},
journal = {Fundamental Research},
year = {2024},
volume = {4},
number = {2},
pages = {237--245},
doi = {10.1016/j.fmre.2023.02.025}
}
EUVIMED